Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PuraMed BioScience
Schofield, Wisconsin, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
PuraMed BioScience developed non-prescription remedies such as LipiGesic M and MigraPure gel targeting migraine relief. Some clinical study results were anticipated around the time of product launches circa early-mid 2010s, but no recent peer-reviewed data or regulatory filings are available. The company also explored cannabinoid-based medicines as of ~2014. No evidence of ongoing late-stage clinical trials or new approvals since then.
- Therapeutic areas
- Neurology
- Modalities
- Small moleculeHerbal/plant-based therapyHomeopathic formulation
- Industry
- Food & Nutrition
02
Partnerships
marketing partnership with Lone Wolf Inc./LWI for social media outreach in the past
Beyond the preview
Go deeper on PuraMed BioScience.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PuraMed BioScience.